Valuation : Merck KGaA

Market Cap 60.91B 70.96B 57.03B 52.22B 98.37B 6,777B 98.65B 675B 264B 3,416B 266B 261B 11,305B P/E 2026 *
23.5x
P/E 2027 * 20.7x
Enterprise Value 68.65B 79.97B 64.27B 58.85B 111B 7,638B 111B 761B 298B 3,850B 300B 294B 12,741B EV / Sales 2026 *
3.19x
EV / Sales 2027 * 2.95x
Free-Float
29.73%
Yield 2026 *
1.68%
Yield 2027 * 1.72%
1 day-0.25%
1 week+1.89%
Current month-2.13%
1 month-2.68%
3 months+8.11%
6 months+11.43%
Current year+14.72%
1 week 136.95
Extreme 136.95
140.05
1 month 135.2
Extreme 135.2
147.4
Current year 100.65
Extreme 100.65
147.95
1 year 100.65
Extreme 100.65
147.95
3 years 100.65
Extreme 100.65
176.5
5 years 100.65
Extreme 100.65
231.3
10 years 74.56
Extreme 74.56
231.3
Manager TitleAgeSince
Chief Executive Officer 60 2026-04-30
Director of Finance/CFO 56 2023-06-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 2019-04-25
Director/Board Member 59 2014-05-08
Director/Board Member 49 2020-05-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%+1.89% - - 70.96B
-2.33%+0.37%+77.88%+35.69% 369B
-0.27%+1.49%+30.17%-13.63% 70.96B
-0.13%+0.75%+46.11%+150.46% 12.14B
+1.74%+2.86%+3.80%+1.10% 8.6B
-2.31%-0.94%-16.02%-0.35% 4.99B
-1.19%+4.65%-28.68%+15.69% 4.46B
+1.34%-11.74%-32.42%+8.76% 3.22B
-1.54%-6.87%-1.95%+40.78% 2.57B
+2.75%-4.05%-15.05%-3.95% 2.2B
Average +0.01%-0.68%+7.09%+26.06% 53.12B
Weighted average by Cap. -0.08%+0.48%+65.08%+29.76%

Financials

2026 *2027 *
Net sales 21.5B 25.04B 20.13B 18.43B 34.72B 2,392B 34.81B 238B 93.16B 1,205B 94.02B 91.99B 3,990B 22.61B 26.33B 21.16B 19.38B 36.51B 2,515B 36.61B 251B 97.96B 1,268B 98.87B 96.74B 4,195B
Net income 2.55B 2.97B 2.39B 2.19B 4.12B 284B 4.13B 28.28B 11.06B 143B 11.16B 10.92B 473B 2.87B 3.34B 2.68B 2.46B 4.63B 319B 4.64B 31.77B 12.42B 161B 12.53B 12.26B 532B
Net Debt 7.74B 9.01B 7.24B 6.63B 12.5B 861B 12.53B 85.79B 33.53B 434B 33.85B 33.11B 1,436B 5.82B 6.77B 5.44B 4.99B 9.39B 647B 9.42B 64.47B 25.2B 326B 25.44B 24.89B 1,079B
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
62,136
Date Price Change Volume
26-08-28 139.90 -0.11% 121
26-08-27 €140.05 +1.12% 14
26-08-26 €138.50 -0.36% 0
26-08-25 €139.00 +0.51% 200
26-08-24 €138.30 +0.73% 8
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
140.10EUR
Average target price
153.50EUR
Spread / Average Target
+9.56%

Quarterly revenue - Rate of surprise